Page 133 - 中国全科医学2022-05

·642· http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn

4735-4745. DOI：10.1038/onc.2014.401. ［50］OGAWA Y，SAITO Y，NISHIO K，et al. Gamma-tocopheryl
［36］TAN F B，ZHU H，HE X，et al. Role of TXNDC5 in quinone，not alpha-tocopheryl quinone，induces adaptive response
tumorigenesis of colorectal cancer cells：In vivo and in vitro through up-regulation of cellular glutathione and cysteine availability
evidence［J］. Int J Mol Med，2018，42（2）：935-945. DOI： via activation of ATF 4 ［J］. Free Radic Res，2008，42（7）：
10.3892/ijmm.2018.3664. 674-687. DOI：10.1080/10715760802277396.
［37］SAMANTA D，SEMENZA G L. Maintenance of redox homeostasis ［51］MIRAHMADI M，AZIMI-HASHEMI S，SABURI E，et al.
by hypoxia-inducible factors［J］. Redox Biol，2017，13：331- Potential inhibitory effect of lycopene on prostate cancer［J］.
335. DOI：10.1016/j.redox.2017.05.022. Biomed Pharmacother，2020，129：110459. DOI：10.1016/j.
［38］ZHANG Y，HAN S J，PARK I，et al. Redox regulation of the biopha.2020.110459.
tumor suppressor PTEN by hydrogen peroxide and tert-butyl ［52］BRATT O. A comparison of lycopene and orchidectomy vs
hydroperoxide［J］. Int J Mol Sci，2017，18（5）：E982. DOI： orchidectomy alone in the management of advanced prostate
10.3390/ijms18050982. cancer［J］. BJU Int，2005，95（1）：192. DOI：
［39］KIM K Y，PARK K I，KIM S H，et al. Inhibition of autophagy 10.1111/j.1464-410X.2005.4440_6.x.
promotes salinomycin-induced apoptosis via reactive oxygen ［53］LIMPENS J，SCHRÖDER F H，DE RIDDER C M，et al.
species-mediated PI3K/AKT/mTOR and ERK/p38 MAPK- Combined lycopene and vitamin E treatment suppresses the growth of
dependent signaling in human prostate cancer cells［J］. Int J Mol PC-346C human prostate cancer cells in nude mice［J］. J Nutr，
Sci，2017，18（5）：E1088. DOI：10.3390/ijms18051088. 2006，136（5）：1287-1293. DOI：10.1093/jn/136.5.1287.
［40］ZHAO J C，FONG K W，JIN H J，et al. FOXA1 Acts upstream
［54］BASAK P，SADHUKHAN P，SARKAR P，et al. Perspectives
of GATA2 and AR in hormonal regulation of gene expression［J］. of the Nrf-2 signaling pathway in cancer progression and
Onc o g e n e ，20 16，35 （33）：433 5-4344 . DOI：
therapy［J］. Toxicol Rep，2017，4：306-318. DOI：10.1016/j.
10.1038/onc.2015.496.
toxrep.2017.06.002.
［41］CHEN H L，LIBERTINI S J，WANG Y，et al. ERK regulates
［55］KHURANA N，SIKKA S C. Targeting crosstalk between nrf-2，
calpain 2-induced androgen receptor proteolysis in CWR22 relapsed
NF-κB and androgen receptor signaling in prostate cancer［J］.
prostate tumor cell lines［J］. J Biol Chem，2010，285（4）：
Cancers（Basel），2018，10（10）：E352. DOI：
2368-2374. DOI：10.1074/jbc.M109.049379.
10.3390/cancers10100352.
［42］KUMARI N，DWARAKANATH B S，DAS A，et al. Role of
［56］SCHULTZ M A，ABDEL-MAGEED A B，MONDAL D. The nrf1
interleukin-6 in cancer progression and therapeutic resistance［J］.
and nrf2 balance in oxidative stress regulation and androgen signaling
Tumour Biol，2016，37（9）：11553-11572. DOI：10.1007/
in prostate cancer cells［J］. Cancers：Basel，2010，2（2）：
s13277-016-5098-7.
1354-1378. DOI：10.3390/cancers2021354.
［43］XU L J，CHEN X D，SHEN M J，et al. Inhibition of IL-6-JAK/
［57］KHURANA N，CHANDRA P K，KIM H，et al. Bardoxolone-
Stat3 signaling in castration-resistant prostate cancer cells enhances
methyl（CDDO-me）suppresses androgen receptor and its splice-
the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D
variant AR-V7 and enhances efficacy of enzalutamide in prostate
ligand levels［J］. Mol Oncol，2018，12（3）：269-286. DOI：
cancer cells［J］. Antioxidants（Basel），2020，9（1）：E68.
10.1002/1878-0261.12135.
DOI：10.3390/antiox9010068.
［44］MOHANTY S K，YAGIZ K，PRADHAN D，et al. STAT3 and
［58］KHURANA N，KIM H，CHANDRA P K，et al. Multimodal
STAT5A are potential therapeutic targets in castration-resistant
actions of the phytochemical sulforaphane suppress both AR and
prostate cancer［J］. Oncotarget，2017，8（49）：85997-
AR-V7 in 22Rv1 cells：Advocating a potent pharmaceutical
86010. DOI：10.18632/oncotarget.20844.
combination against castration-resistant prostate cancer［J］. Oncol
［45］HU T C，YEH J E，PINELLO L，et al. Impact of the N-terminal
Rep，2017，38（5）：2774-2786. DOI：10.3892/or.2017.5932.
domain of STAT3 in STAT3-dependent transcriptional activity［J］.
［59］XU C J，SHEN G X，CHEN C，et al. Suppression of NF-kappaB
Mol Cell Biol，2015，35（19）：3284-3300. DOI：10.1128/
and NF-kappaB-regulated gene expression by sulforaphane and
MCB.00060-15.
PEITC through IkappaBalpha，IKK pathway in human prostate
［46］FENG S T，TANG Q Z，SUN M，et al. Interleukin-6 increases
cancer PC-3 cells［J］. Oncogene，2005，24（28）：4486-
prostate cancer cells resistance to bicalutamide via TIF2［J］. Mol
4495. DOI：10.1038/sj.onc.1208656.
Cancer Ther，2009，8（3）：665-671. DOI：10.1158/1535-
［60］ZHOU D Y，ZHAO S Q，DU Z Y，et al. Pyridine analogues
7163.MCT-08-0823.
［47］VIVARELLI F，CANISTRO D，CIRILLO S，et al. Co- of curcumin exhibit high activity for inhibiting CWR-22Rv1
carcinogenic effects of vitamin E in prostate［J］. Sci Rep，2019， human prostate cancer cell growth and androgen receptor
9（1）：11636. DOI：10.1038/s41598-019-48213-1. activation［J］. Oncol Lett，2016，11（6）：4160-4166. DOI：
［48］VANCE T M，SU J，FONTHAM E T，et al. Dietary antioxidants 10.3892/ol.2016.4536.
and prostate cancer：a review［J］. Nutr Cancer，2013，65（6）： ［61］SHIN J W，CHUN K S，KIM D H，et al. Curcumin
793-801. DOI：10.1080/01635581.2013.806672. induces stabilization of Nrf2 protein through Keap1 cysteine
［49］HUANG Y，KHOR T O，SHU L M，et al. A γ-tocopherol-rich modification［J］. Biochem Pharmacol，2020，173：113820.
mixture of tocopherols maintains Nrf2 expression in prostate tumors DOI：10.1016/j.bcp.2020.113820.
of TRAMP mice via epigenetic inhibition of CpG methylation［J］. （收稿日期：2021-07-10；修回日期：2021-12-10）
J Nutr，2012，142（5）：818-823. DOI：10.3945/jn.111.153114. （本文编辑：张小龙）